SynBiotic focuses on the research and development of cannabinoids for usage in medicinal purposes, cosmetics and dietary supplements.
SynBiotic has raised €10M across 2 funding rounds from 1 investor, most recently a round in Aug 2023. Based in Munich, Germany; active in Agritech and Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2023-08-22 | Other | €3.0M | Frank Otto | View deal → |
| 2021-10-27 | Other | €7.0M | — | View deal → |
